144 related articles for article (PubMed ID: 31032425)
1. Compare Fuhrman Nuclear and Chromophobe Tumor Grade on Chromophobe RCC.
Lin TF; Lin WR; Chen M; Dai SH; Sun FJ; Tsai WK; Chiu AW
Open Med (Wars); 2019; 14():336-342. PubMed ID: 31032425
[TBL] [Abstract][Full Text] [Related]
2. Application and comparison of Fuhrman nuclear grading system with the novel tumor grading system for chromophobe renal cell carcinoma and its correlation with disease-specific events.
Sali AP; Bahirwade GK; Bakshi G; Prakash G; Joshi A; Desai SB; Menon S
Indian J Urol; 2021; 37(2):147-152. PubMed ID: 34103797
[TBL] [Abstract][Full Text] [Related]
3. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
4. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.
Finley DS; Shuch B; Said JW; Galliano G; Jeffries RA; Afifi AA; Castor B; Magyar C; Sadaat A; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2011 Dec; 186(6):2168-74. PubMed ID: 22014797
[TBL] [Abstract][Full Text] [Related]
5. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis.
Avulova S; Cheville JC; Lohse CM; Gupta S; Potretzke TA; Tsivian M; Thompson RH; Boorjian SA; Leibovich BC; Potretzke AM
Eur Urol; 2021 Feb; 79(2):225-231. PubMed ID: 33172723
[TBL] [Abstract][Full Text] [Related]
6. Relating prognosis in chromophobe renal cell carcinoma to the chromophobe tumor grading system.
Weinzierl EP; Thong AE; McKenney JK; Jeon SH; Chung BI
Korean J Urol; 2014 Apr; 55(4):239-44. PubMed ID: 24741411
[TBL] [Abstract][Full Text] [Related]
7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
[TBL] [Abstract][Full Text] [Related]
9. The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma.
Steffens S; Janssen M; Roos FC; Becker F; Steinestel J; Abbas M; Steinestel K; Wegener G; Siemer S; Thüroff JW; Hofmann R; Stöckle M; Schrader M; Hartmann A; Hasenfus A; Kuczyk MA; Junker K; Schrader AJ;
Hum Pathol; 2014 Dec; 45(12):2411-6. PubMed ID: 25305793
[TBL] [Abstract][Full Text] [Related]
10. External validation of a four-tiered grading system for chromophobe renal cell carcinoma.
Liu S; Hou M; Yao Y; Mei J; Sun L; Zhang G
Clin Exp Med; 2024 Mar; 24(1):61. PubMed ID: 38554222
[TBL] [Abstract][Full Text] [Related]
11. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
12. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
[TBL] [Abstract][Full Text] [Related]
13. Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size.
Steffens S; Roos FC; Janssen M; Becker F; Steinestel J; Abbas M; Steinestel K; Wegener G; Siemer S; Thüroff JW; Hofmann R; Stöckle M; Schrader M; Hartmann A; Junker K; Kuczyk MA; Schrader AJ;
Virchows Arch; 2014 Oct; 465(4):439-44. PubMed ID: 25178561
[TBL] [Abstract][Full Text] [Related]
14. Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: a comparison with conventional renal cell carcinoma.
Ku JH; Moon KC; Kwak C; Kim HH
Urol Oncol; 2011; 29(5):487-91. PubMed ID: 19767221
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.
Mytsyk Y; Dutka I; Borys Y; Komnatska I; Shatynska-Mytsyk I; Farooqi AA; Gazdikova K; Caprnda M; Rodrigo L; Kruzliak P
Int Urol Nephrol; 2017 Feb; 49(2):215-224. PubMed ID: 27853915
[TBL] [Abstract][Full Text] [Related]
16. Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme.
Ohashi R; Martignoni G; Hartmann A; Caliò A; Segala D; Stöhr C; Wach S; Erlmeier F; Weichert W; Autenrieth M; Schraml P; Rupp NJ; Ohe C; Otsuki Y; Kawasaki T; Kobayashi H; Kobayashi K; Miyazaki T; Shibuya H; Usuda H; Umezu H; Fujishima F; Furusato B; Osakabe M; Sugai T; Kuroda N; Tsuzuki T; Nagashima Y; Ajioka Y; Moch H
Virchows Arch; 2020 Mar; 476(3):409-418. PubMed ID: 31760491
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of clinicopathological features and prognosis in 68 patients with chromophobe renal cell carcinoma].
Huang JW; Zhang J; Dong BJ; Kong W; Niu SX; Chen YH; Xue W; Liu DM; Huang YR
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):510-3. PubMed ID: 22967469
[TBL] [Abstract][Full Text] [Related]
18. Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution.
Przybycin CG; Cronin AM; Darvishian F; Gopalan A; Al-Ahmadie HA; Fine SW; Chen YB; Bernstein M; Russo P; Reuter VE; Tickoo SK
Am J Surg Pathol; 2011 Jul; 35(7):962-70. PubMed ID: 21602658
[TBL] [Abstract][Full Text] [Related]
19. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
[TBL] [Abstract][Full Text] [Related]
20. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation.
Lichtbroun BJ; Shinder B; Sara TG; Srivastava A; Saraiya B; Mayer TM; Cristelli R; Sadimin E; Weiss RE; Singer EA
J Kidney Cancer VHL; 2023; 10(3):1-8. PubMed ID: 37441361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
